CuraTeQ Biologics s.r.o
3 products tracked · names used in filings: CuraTeQ Biologics s.r.o
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 25 Sep 2026🇪🇺 EU approval (EC decision)
Cavoley (pegfilgrastim) approved in the EU
Marketing authorisation to CuraTeQ Biologics s.r.o; Biosimilar, Additional monitoring · source
Thu 23 Jul 2026🇪🇺 CHMP positive opinion
Cavoley (pegfilgrastim): CHMP positive opinion
CuraTeQ Biologics s.r.o; Biosimilar, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Dyrupeg pegfilgrastim | Application withdrawn | |
| 🇪🇺 | Zefylti filgrastim | Application withdrawn | |
| 🇪🇺 | Cavoley pegfilgrastim | Authorised | 2026-09-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.